He Pan, Tang Haitian, Zheng Yating, Xu Xiao, Peng Xuqi, Jiang Tao, Xiong Yongfu, Zhang Yang, Zhang Yu, Liu Gang
Department of Hepatobiliary and Pancreas Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 611731, China.
Department of General Surgery, Institute of Hepatobiliary-Pancreatic-Intestinal Diseases, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, China.
Theranostics. 2025 Jan 1;15(3):1017-1034. doi: 10.7150/thno.102671. eCollection 2025.
Recent innovations in medical imaging technology have placed molecular imaging techniques at the forefront of diagnostic advancements. The current research trajectory in this field aims to integrate personalized molecular data of patients and diseases with traditional anatomical imaging data, enabling more precise, non-invasive, or minimally invasive diagnostic options for clinical medicine. This article provides an in-depth exploration of the basic principles and system components of optical molecular imaging technology. It also examines commonly used targeting mechanisms of optical probes, focusing especially on indocyanine green-the FDA-approved optical dye widely used in clinical settings-and its specific applications in diagnosing and treating liver cancer. Finally, this review highlights the advantages, limitations, and future challenges facing optical molecular imaging technology, offering a comprehensive overview of recent advances, clinical applications, and potential impacts on liver cancer treatment strategies.
医学成像技术的最新创新已将分子成像技术置于诊断进步的前沿。该领域当前的研究轨迹旨在将患者和疾病的个性化分子数据与传统解剖成像数据相结合,从而为临床医学提供更精确、非侵入性或微创的诊断选择。本文深入探讨了光学分子成像技术的基本原理和系统组件。它还研究了光学探针常用的靶向机制,特别关注吲哚菁绿——一种经美国食品药品监督管理局批准、广泛应用于临床的光学染料——及其在肝癌诊断和治疗中的具体应用。最后,本综述强调了光学分子成像技术面临的优势、局限性和未来挑战,全面概述了近期进展、临床应用以及对肝癌治疗策略的潜在影响。